Effectiveness of Third Occipital Nerve Pulsed Radiofrequency in Cervicogenic Headache

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAnkara City Hospital Bilkent

About this trial

Cervicogenic headache is a secondary headache disorder originating from cervical spine structures and is frequently associated with chronic pain, functional limitation, and impaired quality of life. The third occipital nerve, which innervates the C2-3 zygapophyseal joint, plays an important role in the pathophysiology of cervicogenic headache.

Pulsed radiofrequency is a minimally invasive interventional pain management technique that modulates nociceptive transmission without causing permanent neural damage. Although third occipital nerve pulsed radiofrequency is increasingly used in clinical practice, prospective data evaluating its clinical effectiveness and safety remain limited.

The aim of this prospective, single-center study is to evaluate the effectiveness and safety of ultrasound-guided third occipital nerve pulsed radiofrequency treatment in patients diagnosed with cervicogenic headache. Pain intensity, headache characteristics, analgesic consumption, and patient-reported outcomes will be assessed before treatment and during follow-up. The results of this study are expected to contribute to clinical evidence supporting interventional treatment strategies for cervicogenic headache.

Eligibility criteria

Qualifiers

Age 18 years or older

Diagnosis of cervicogenic headache according to the International Classification of Headache Disorders, 3rd edition (ICHD-3)

Availability of cranial and cervical spine imaging

At least 5 headache days per month

Disqualifiers

Secondary headache disorders other than cervicogenic headache according to ICHD-3

Signs or symptoms of cervical nerve root irritation and/or spinal stenosis

Sensory deficit in the greater occipital nerve dermatome

Cranio-cervical structural defects or anatomical abnormalities at or near the target site

Trial design

Treatments tested in this trial

  • Third Occipital Nerve Pulsed Radiofrequency

Treatment groups

25 Participants
are divided into 1 treatment group

Sponsors and collaborators